Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.370
-0.020 (-0.84%)
Nov 20, 2024, 4:00 PM EST - Market closed
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $142.39 million as of November 21, 2024. Its market cap has increased by 17.73% in one year.
Market Cap
142.39M
Enterprise Value
-86.52M
1-Year Change
17.73%
Ranking
Category
Stock Price
$2.37
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $142.39M, a decrease of -76.98%. That is a compound annual growth rate of -35.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 142.39M | -35.97% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Skye Bioscience | 138.34M |
| Sensus Healthcare | 137.83M |
| Pro-Dex | 136.76M |
| Seer, Inc. | 136.21M |
| PepGen | 134.62M |
| Puma Biotechnology | 134.50M |
| Zentek | 132.60M |
| Inhibikase Therapeutics | 132.37M |